🇯🇵
COUNTRY FEED
Clinical Trials in Japan
Active recruiting clinical trials with sites in Japan. Select a condition below to see detailed trial listings.
Total Trials: 69 // Recruiting: 69 // Updated: Daily
Japan currently has 69 clinical trials with at least one registered site in the country, of which 69 are actively recruiting participants. The most studied conditions at Japan sites are Gastric Cancer, Solid Tumors, Obesity, reflecting where local investigators and sponsors are concentrating enrolment.
Studies are led by sponsors including GlaxoSmithKline, Bristol-Myers Squibb, Takeda. By stage, active Japan trials break down as Phase 1 (15), Phase 2 (16), Phase 3 (19), Phase 4 (1). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.
Top Conditions in Japan
Gastric Cancer 3 Solid Tumors 2 Obesity 2 Pancreatic Cancer 2 Breast Cancer 2 Hyperphosphatemia Patients on Hemodialysis 2 ST-segment Elevation Myocardial Infarction (STEMI) 1 Life Threatening Bleeding 1 Factor Xa Inhibitor 1 Systemic Lupus Erythematosus 1 IO-resistant sqNSCLC 1 Schizophrenia 1 Attention-Deficit Hyperactivity Disorder(ADHD) 1 Solid Tumours 1 Solid Tumor 1 Gastrointestinal Stromal Neoplasms 1 Metabolic Dysfunction-Associated SteatoHepatitis (MASH) 1 Recurrent Head and Neck Squamous Cell Carcinoma 1 Neoplasms, Endometrial 1 Overweight 1
Other Countries in This Region
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology